AHA News writes: At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data.
MedPAC Examines Medicare Quality Measurement, Drug Spending
More from United StatesMore posts in United States »
- CMS-1754-F Final Rule for Changes to Home Health Quality Reporting Program
- CMS-1748-F Final Rule for FY 2022 Inpatient Rehabilitation Facilities Quality Reporting Program
- CMS-1746-F: Final Rule for FY 2022 Skilled Nursing Facility Quality Reporting Program
- Report Finds Declining Volume in Pediatric, Maternal and Newborn Departments in U.S Health Systems, Uptake in Pediatric ICU Visits
- New Release: Massachusetts Acute Care Hospital Quarterly Update (October 2018 – March 2021)